Corporate Banner
Satellite Banner
Chemical Process Scale Up
Scientific Community
Become a Member | Sign in
Home>News>This Article

SCM to Deliver Vial Filling Project

Published: Friday, February 10, 2012
Last Updated: Friday, February 10, 2012
Bookmark and Share
BrePco selects CDMO to initially produce clinical batches for eight clinical trial sites.

SCM Pharma is to develop and manufacture an injectable neonatal product for BrePco BioPharma to be used in a clinical trial researching the treatment of critically ill premature babies suffering from hypotension.

Ireland-based BrePco selected the development and contract manufacturing organization (CDMO) to initially produce development and clinical batches for eight clinical trial sites across Canada and Europe and then scale-up to commercial production should the product get licensed.

In line with SCM Pharma’s expertise in filling sterile products, this latest vial filling project involves the product needing to be presented as a terminally sterilized vial.

The CDMO has already manufactured engineering batches and will commence work on a stability study with process validation batches next in the project plan.

The product is based on an established and approved inotropic agent. However, the currently approved drugs were developed for adults and are not specifically licensed for use in children.

The aim of the trial is to therefore develop a ready-to-use, licensed treatment for vulnerable preterm infants.

Paul Breen, co-founder and chairman at BrePco Biopharma, said: “With a few years of research already completed on the project, we needed a drug manufacturing partner like SCM Pharma that has a proven track record both in terms of quality and its capability to manufacture products for clinical trials.

“It was vital for us to have a contract manufacturing organization that not only understood the challenges of clinical manufacturing but could also provide the potential to scale up to commercial production when required.

“The project is progressing well and already the SCM team has shown its technical ability and commitment to meet our deadlines and deliver the project to the available budget.”

BrePco along with 12 research partners across Ireland, Europe and Canada led by Cork University Maternity Hospital secured €5.6m from the European Commission's Healthcare FP7 Programme for the project last year.

This was based on hypotension (low blood pressure) being a common problem amongst very premature infants and is often associated with tragic outcomes, including brain injury and death.

At present, the existing licensed product is typically diluted before use depending on the dosage required but involves a challenging administration process, as it is usually needed immediately following birth of a low weight child.

Dianne Sharp, managing director at SCM Pharma, said: “This project with BrePco is a very significant one given the beneficiaries of the product. With our established vial filling capability, we will be working closely with the BrePco team to fast track their project as quickly as possible to help them meet their clinical trial deadlines.”

SCM Pharma is specialist in the global contract drug manufacturing market with its ability to provide cGMP sterile services for C-14 radiolabeling and potent products such as cytotoxics.

The contract filling specialist offers aseptic processing and sterile manufacturing services to pharma companies across the world and along with vials, has specific expertise in ampoule filling and syringe filling of liquids, gels and powders.

At the back-end of last year, SCM Pharma launched its own formulation development capability after acquiring new facilities at the University of Sunderland.

The company now provides developmental services for liquid formulations including emulsions and suspensions for parenteral, oral and topical administration using either proprietary or customers’ novel delivery systems.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

MHRA Approves New SCM Pharma Commercial Facility
SCM Pharma’s new £6m ($10m) pharmaceutical contract manufacturing facility has been given the go ahead.
Thursday, June 20, 2013
SCM to Support BTG NDA
Will provide scale up for Varisolve launch.
Friday, April 26, 2013
Scientific News
Injecting New Life into Old Antibiotics
A new fully synthetic way to make a class of antibiotics called macrolides from simple building blocks is set to open up a new front in the fight against antimicrobial drug resistance.
New Cancer Fighters Emerge From Lab
Rice University lab simplifies total synthesis of anti-cancer agent.
Pharmacy on Demand
New, portable system can be configured to produce different drugs.
Safer, Cheaper, Greener and More Efficient System for Organic Synthesis
The new medium not only supports organic synthesis it also produces considerably higher yields of product than pure organic solvents.
Countless New, Cleaner Uses of Methane
Chemists have demonstrated the potential to use methane as a versatile chemical building block with which to make more complex molecules.
New Way to Control Chemical Reactions
Scientists have harnessed static electricity to control chemical reactions for the first time, in a breakthrough that could bring cleaner industry and cheaper nanotechnology.
Tiny 'Flasks' Speed Up Chemical Reactions
Self-assembling nanosphere clusters may improve everything from drug synthesis to drug delivery.
The Manufacturing Challenges of Nanotechnology
Head of NanoManufacturing at the Department of Engineering’s Institute for Manufacturing (IfM) Dr Michaël de Volder explains why manufacturing carbon nanotubes is so difficult – and so important.
New Material Lays Waste to Mercury Pollution
A brand new, dirt cheap, non-toxic polymer that literally sucks mercury out of water and soil is set to become a game changer in the battle against one of the world’s most reviled pollutants.
Shocking New Way to Get the Salt Out
MIT team invents efficient shockwave-based process for desalination of water.

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos